OTLK
Outlook Therapeutics, Inc.
$0.28+0.00 (0.00%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Oncobiologics, Inc. (ONS) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
Showing 10 of 17 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025-10-03 | 2025-10-03 | Haddadin Yezan Munther | Director | Award | 95,969 | $0.00 | $0 | N/A | N/A |
| 2025-10-03 | 2025-10-03 | Huang Andong | Director | Award | 53,316 | $0.00 | $0 | N/A | N/A |
| 2025-10-03 | 2025-10-03 | Hilzinger Kurt J | Director | Award | 90,638 | $0.00 | $0 | N/A | N/A |
| 2025-10-03 | 2025-10-03 | Auffarth Gerd | Director | Award | 58,648 | $0.00 | $0 | N/A | N/A |
| 2025-10-03 | 2025-10-03 | Sukhtian Faisal Ghiath | Director | Award | 117,296 | $0.00 | $0 | N/A | N/A |
| 2025-10-03 | 2025-10-03 | Haller Julia A | Director | Award | 58,648 | $0.00 | $0 | N/A | N/A |
| 2025-10-03 | 2025-10-01 | Thurman Randy H | Director | Award | 286,734 | $0.00 | $0 | N/A | N/A |
| 2025-10-03 | 2025-10-01 | Huang Andong | Director | Award | 286,734 | $0.00 | $0 | N/A | N/A |
| 2025-10-03 | 2025-10-01 | Sukhtian Faisal Ghiath | Director | Award | 286,734 | $0.00 | $0 | N/A | N/A |
| 2025-10-03 | 2025-10-01 | Auffarth Gerd | Director | Award | 286,734 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.